Regarding anemic patients with non-dialysis CKD, KDIGO guidelines recommend iron therapy in order to reduce ESA doses or to increase Hb levels with a trial of intravenous or oral iron for patients with ferritin ≤500 μg/L and TSAT ≤30% [37]. Here, GSTM1 is linked to chronic kidney disease.